Reverse remodelling of the heart after atrial fibrillation ablation in patients with heart failure with reduced ejection fraction

Aim. To evaluate the effect of atrial fibrillation (AF) catheter ablation (CA) on long-term freedom from AF and left heart reverse remodeling in patients with heart failure with reduced ejection fraction (HFrEF).

Methods. There were 47 patients (mean age 53.3 ± 10 years, 39 males) enrolled into single-center observational study, with left ventricular ejection fraction (LVEF) <40 %. Patients underwent CA for AF refractory to antiarrhythmic drugs. Baseline clinical data and diagnostic tests results were obtained during personal visits and / or via secure telemedical services. Personal contact with evaluation of recurrence of AF and echocardiographic values was performed with 30 (64 %) patients.

Results. Paroxysmal AF was present in 12 (40 %) patients, persistent – in 18 (60 %). During mean follow-up of 3 years (0.5–6 years) redo ablation was performed in 9 patients (30 %) with average number of 1.3 procedures per patient. At 6 months 24 (80 %) patients were free from AF, at last follow-up – 16 (53 %). The mean time to first recurrence following CA was 15.6±13.3 months. Follow-up echocardiography revealed significant LVEF improvement (р<0,0001), reduction of left atrium size (р<0,0001), left ventricle end-diastolic volume (р<0,002) and left ventricle endsystolic volume (p<0,0001) and mitral regurgitation (р=0,001).

Conclusion. AF CA in patients with HFrEF is associated with improvement in systolic function and left heart reverse remodeling. Durable long-term antiarrhythmic effect often requires repeated procedures.

1. Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5):484–92. DOI: 10.1161/CIRCULATIONAHA.115.018614

2. Heist EK, Ruskin JN. Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment. Progress in Cardiovascular Diseases. 2006;48(4):256–69. DOI: 10.1016/j.pcad.2005.09.001

3. Lobel RM, Lustgarten DL. Treatment of Arrhythmias in Patients with Congestive Heart Failure. Current Treatment Options in Cardiovascular Medicine. 2004;6(6):519–29. PMID: 15496269

4. Lubitz SA, Benjamin EJ, Ellinor PT. Atrial fibrillation in congestive heart failure. Heart Failure Clinics. 2010;6(2):187–200. DOI: 10.1016/j.hfc.2009.11.001

5. Cha Y-M, Redfield MM, Shen W-K, Gersh BJ. Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle. Circulation. 2004;109(23):2839–43. DOI: 10.1161/01.CIR.0000132470.78896.A8

6. Al Halabi S, Qintar M, Hussein A, Alraies MC, Jones DG, Wong T et al. Catheter Ablation for Atrial Fibrillation in Heart Failure Patients. JACC: Clinical Electrophysiology. 2015;1(3):200–9. DOI: 10.1016/j.jacep.2015.02.018

7. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation. 2016;133(17):1637– 44. DOI: 10.1161/CIRCULATIONAHA.115.019406

8. Liang JJ, Callans DJ. Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction. Cardiac Failure Review. 2018;4(1):33–37. DOI: 10.15420/cfr.2018:3:1

9. Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V et al. A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial). Circulation: Arrhythmia and Electrophysiology. 2014;7(1):31–8. DOI: 10.1161/CIRCEP.113.000806

10. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. New England Journal of Medicine. 2018;378(5):417–27. DOI: 10.1056/NEJMoa1707855

11. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. 2016;18(8):891–975. DOI: 10.1002/ejhf.592

12. Sulimov V.A., Golitsin S.P., Panchenko E.P., Popov S.V., Revishvili A Sh., Shubik Yu.V. et al. Diagnosis and treatment of atrial fibrillation. Recommendations of RSC, RSSA and ACVS. Russian Journal of Cardiology. 2013;18 (4 S3):1–100. Russian

13. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38):2893–962. DOI: 10.1093/eurheartj/ehw210

14. Tzou WS, Marchlinski FE, Zado ES, Lin D, Dixit S, Callans DJ et al. Long-Term Outcome After Successful Catheter Ablation of Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2010;3(3):237–42. DOI: 10.1161/CIRCEP.109.923771

15. Wynn GJ, Das M, Bonnett LJ, Panikker S, Wong T, Gupta D. Efficacy of Catheter Ablation for Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis of Evidence from Randomized and Nonrandomized Controlled Trials. Circulation: Arrhythmia and Electrophysiology. 2014;7(5):841–52. DOI: 10.1161/CIRCEP.114.001759

16. Desai Y, Levy MR, Iravanian S, Clermont EC, Kelli HM, Eisner RL et al. Clinical and anatomic predictors of need for repeat atrial fibrillation ablation. World Journal of Cardiology. 2017;9(9):742–8. DOI: 10.4330/wjc.v9.i9.742

17. Wang TJ. Obesity and the Risk of New-Onset Atrial Fibrillation. JAMA. 2004;292(20):2471–7. DOI: 10.1001/jama.292.20.2471

18. Hsu L-F, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F et al. Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure. New England Journal of Medicine. 2004;351(23):2373–83. DOI: 10.1056/NEJMoa041018

19. Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. EP Europace. 2018;20(1):33–42. DOI: 10.1093/europace/eux013

20. Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275–444. DOI: 10.1016/j.hrthm.2017.05.012

21. Caldeira D, David C, Sampaio C. Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials. Archives of Cardiovascular Diseases. 2012;105(4):226–38. DOI: 10.1016/j.acvd.2011.11.005

22. Smer A, Salih M, Darrat YH, Saadi A, Guddeti R, Mahfood Haddad T et al. Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction. Clinical Cardiology. 2018;41(11):1430–8. DOI: 10.1002/clc.23068

23. Malhi N, Hawkins NM, Andrade JG, Krahn AD, Deyell MW. Catheter ablation of atrial fibrillation in heart failure with reduced ejection fraction. Journal of Cardiovascular Electrophysiology. 2018;29(7):1049–58. DOI: 10.1111/jce.13497

24. Zhu P, Zhang Y, Jiang P, Wang Z, Wang J, Yin X et al. Effects of radiofrequency catheter ablation on left ventricular structure and function in patients with atrial fibrillation: a meta-analysis. Journal of Interventional Cardiac Electrophysiology. 2014;40(2):137–45. DOI: 10.1007/s10840-014-9903-1

25. Anselmino M, Grossi S, Scaglione M, Castagno D, Bianchi F, Senatore G et al. Long-Term Results of Transcatheter Atrial Fibrillation Ablation in Patients with Impaired Left Ventricular Systolic Function. Journal of Cardiovascular Electrophysiology. 2013;24(1):24–32. DOI: 10.1111/j.1540-8167.2012.02419.x